KADFER REPORT AT LÊ NGỌC TÙNG GENERAL HOSPITAL

On June 15, 2026, Medbolide Pharmaceutical JSC participated in a scientific seminar organized by Lê Ngọc Tùng General Hospital. The seminar was attended by doctors, pharmacists, and other medical staff from the hospital.

Company representatives presented recommendations and clinical studies demonstrating the superior efficacy of 0.25 mg dequalinium chloride, a broad-spectrum antimicrobial agent with antibacterial and antifungal properties and a high safety profile. Following the presentation, the doctors discussed the product and expressed interest in Kadfer (0.25 mg dequalinium chloride). It is an effective and safe treatment option for patients with common oral and throat conditions such as Vincent’s angina, pharyngitis, sore throat, tonsillitis, stomatitis, aphthous ulcers, thrush, and glossitis.

At the conclusion of the report, Medbolide expressed its gratitude and hope to continue partnering with Lê Ngọc Tùng General Hospital in providing solutions that improve patients’ quality of life.